<DOC>
	<DOCNO>NCT02860806</DOCNO>
	<brief_summary>The purpose study characterize single-dose pharmacokinetic ( PK ) single escalate intravenous ( IV ) dose JNJ-63623872 administer continuous infusion ; evaluate safety tolerability single escalate IV dos JNJ-63623872 administer continuous infusion ; characterize single-dose PK JNJ-63623872 one select dose administer continuous IV infusion various duration characterize single- repeat-dose PK JNJ-63623872 administer continuous infusion .</brief_summary>
	<brief_title>Safety , Tolerability , Pharmacokinetic Absolute Bioavailability Study JNJ-63623872 Administered Intravenous Infusion 600-Milligram ( mg ) Oral Dose Healthy Adults</brief_title>
	<detailed_description />
	<criteria>A female participant ( except postmenopausal ) must negative serum beta human chorionic gonadotropin ( betahCG ) pregnancy test screen Day 1 treatment period A woman must agree donate egg ( ovum , oocytes ) purpose assist reproduction study period 90 day discontinuation study drug During study minimum 1 spermatogenesis cycle ( define approximately 90 day ) receive last dose study drug , addition highly effective method contraception female partner , man regardless vasectomize : 1 ) sexually active woman childbearing potential must agree use barrier method contraception ( example , condom spermicidal foam/gel/film/cream/suppository ) , 2 ) must agree donate sperm 3 ) sexually active pregnant woman must use condom Must Body Mass Index ( BMI ) ; weight kilogram [ kg ] /height^2 [ ] ^2 ) 18.0 30.0 kilogram per meter square ( kg/m^2 ) ( extremes include ) Screening Must blood pressure ( supine least 5 minute rest stand least 1 minute stand ) 90 140 mmHg systolic , inclusive , high 90 mmHg diastolic Screening Has history current clinically significant medical illness include ( limited ) cardiac arrhythmia cardiac disease , hematologic disease , coagulation disorder ( include abnormal bleeding blood dyscrasia ) , lipid abnormality , significant pulmonary disease , include bronchospastic respiratory disease , diabetes mellitus , hepatic renal insufficiency , thyroid disease , neurologic psychiatric disease , infection , illness investigator considers exclude participant could interfere interpretation study result With past history heart arrhythmia ( extrasystoli , tachycardia rest ) , history risk factor Torsade de Pointes syndrome ( example , hypokalemia , family history long QT Syndrome ) Has know allergy , hypersensitivity , intolerance JNJ63623872 excipients With history clinically significant skin disease , limited , dermatitis , eczema , drug rash , psoriasis , food allergy , urticaria With history clinically significant drug allergy , limited , sulfonamides penicillin , drug allergy diagnose previous study experimental drug Has history hepatitis B surface antigen ( HBsAg ) hepatitis C antibody ( antiHCV ) positive , clinically active liver disease , test positive HBsAg antiHCV Screening Has history human immunodeficiency virus ( HIV ) antibody positive , test positive HIV Screening</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>